4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
US8071567B2 · kind B2 · utility
42Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2009 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Sep 16, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of nucleoside derivatives of formula Iawherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.